JP2007522210A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522210A5
JP2007522210A5 JP2006553086A JP2006553086A JP2007522210A5 JP 2007522210 A5 JP2007522210 A5 JP 2007522210A5 JP 2006553086 A JP2006553086 A JP 2006553086A JP 2006553086 A JP2006553086 A JP 2006553086A JP 2007522210 A5 JP2007522210 A5 JP 2007522210A5
Authority
JP
Japan
Prior art keywords
amino
carboxamide
methyl
ethyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006553086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522210A (ja
Filing date
Publication date
Priority claimed from SE0400284A external-priority patent/SE0400284D0/xx
Application filed filed Critical
Publication of JP2007522210A publication Critical patent/JP2007522210A/ja
Publication of JP2007522210A5 publication Critical patent/JP2007522210A5/ja
Pending legal-status Critical Current

Links

JP2006553086A 2004-02-10 2005-02-07 JAK3キナーゼ修飾物質としての新規なキノリン−カルボキシアミド(carbaxamide) Pending JP2007522210A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400284A SE0400284D0 (sv) 2004-02-10 2004-02-10 Novel compounds
PCT/SE2005/000156 WO2005075429A1 (en) 2004-02-10 2005-02-07 Novel quinoline-carbaxamides as jack3 kinase modulators

Publications (2)

Publication Number Publication Date
JP2007522210A JP2007522210A (ja) 2007-08-09
JP2007522210A5 true JP2007522210A5 (enExample) 2008-03-21

Family

ID=31885281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553086A Pending JP2007522210A (ja) 2004-02-10 2005-02-07 JAK3キナーゼ修飾物質としての新規なキノリン−カルボキシアミド(carbaxamide)

Country Status (9)

Country Link
US (1) US20080153799A1 (enExample)
EP (1) EP1718615A1 (enExample)
JP (1) JP2007522210A (enExample)
CN (1) CN1942445A (enExample)
AR (1) AR047609A1 (enExample)
SE (1) SE0400284D0 (enExample)
TW (1) TW200529838A (enExample)
UY (1) UY28745A1 (enExample)
WO (1) WO2005075429A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297700B2 (en) 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
US7470787B2 (en) * 2005-07-11 2008-12-30 Aerie Pharmaceuticals, Inc. Isoquinoline compounds
TWI464148B (zh) 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
ATE478849T1 (de) * 2006-04-14 2010-09-15 Astrazeneca Ab 4-anilinochinolin-3-carbonsäureamide als csf-1r- kinaseinhibitoren
JP5235887B2 (ja) 2006-09-20 2013-07-10 アエリー ファーマシューティカルズ インコーポレイテッド Rhoキナーゼ阻害剤
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
US8455513B2 (en) * 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
JO2704B1 (en) 2007-09-21 2013-03-03 جانسين فارماسوتيكا ان في Interference inhibition factors between MD2 and B53
US8455514B2 (en) * 2008-01-17 2013-06-04 Aerie Pharmaceuticals, Inc. 6-and 7-amino isoquinoline compounds and methods for making and using the same
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
JPWO2010058846A1 (ja) * 2008-11-21 2012-04-19 アステラス製薬株式会社 4,6−ジアミノニコチンアミド化合物
EA021367B1 (ru) 2008-11-28 2015-06-30 Кова Компани, Лтд. Производное пиридин-3-карбоксамида
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
CA2762232A1 (en) * 2009-05-20 2010-11-25 Clanotech Ab Substituted quinolines for use as vegf inhibitors
US20130225524A1 (en) * 2010-11-05 2013-08-29 Deping Chai Chemical Compounds
AU2014216178B2 (en) 2013-02-15 2018-06-28 KALA BIO, Inc. Therapeutic compounds and uses thereof
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
EP2958895B1 (en) 2013-02-20 2020-08-19 Kala Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
PT3811943T (pt) 2013-03-15 2023-03-15 Aerie Pharmaceuticals Inc Composto para uso no tratamento de distúrbios oculares
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA2928658A1 (en) 2013-11-01 2015-05-07 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
WO2017086941A1 (en) 2015-11-17 2017-05-26 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
US11389441B2 (en) 2016-08-31 2022-07-19 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
CA3036340A1 (en) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA3036065A1 (en) 2016-09-08 2018-03-15 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
AU2017324713B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN111269215B (zh) * 2020-04-01 2021-10-26 中科利健制药(广州)有限公司 含氮杂环有机化合物及其制备方法和应用
TW202345806A (zh) 2022-03-31 2023-12-01 美商艾伯維有限公司 噻唑并〔5,4-b〕吡啶malt-1抑制劑

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362954A (en) * 1965-08-12 1968-01-09 Sterling Drug Inc 4-tertiary amino-lower alkylamino-quinoline carboxamides and carboxylates
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
GB8804447D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
WO1991014677A1 (en) * 1990-03-28 1991-10-03 Otsuka Pharmaceutical Co., Ltd. Quinoline derivative, antiulcer drug containing the same, and production of said derivative
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
SE0101675D0 (sv) * 2001-05-11 2001-05-11 Astrazeneca Ab Novel composition

Similar Documents

Publication Publication Date Title
JP2007522210A5 (enExample)
US20080153799A1 (en) Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators
US7329753B2 (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US6897224B2 (en) Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
CA2849169C (en) Pyrazole carboxamides as janus kinase inhibitors
US7790740B2 (en) Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation
TWI449696B (zh) 以5員雜環為主之p38激酶抑制劑
JP2002506858A (ja) Cmv感染症の治療に有用な1,3,4−チアジアゾール
JP2003507456A (ja) ケモカインレセプター活性のモジュレーターとして有用な置換ピペリジン化合物
JP2003513090A (ja) N置換カルバモイルオキシアルキルアゾリウム誘導体
CZ20011563A3 (cs) Tricyklické pyrazolové deriváty
MXPA02003533A (es) Derivados de pirimidina.
CN1473154A (zh) 2,3-二氮杂萘酮衍生物
TW297813B (enExample)
KR20010081034A (ko) 피페리딘 씨씨알-3 수용체 길항제
AU2005316511B2 (en) Compounds and compositions as modulators of steroidal receptors and calcium channel activities
MX2008012031A (es) Derivado de triazolona.
UA108746C2 (xx) Заміщені ізохінолінони та хіназолінони
JP2008501672A (ja) ケモカイン受容体アンタゴニストとしてのチアゾール誘導体
WO1999054307A1 (en) Pyrazolinone derivatives
JP6200495B2 (ja) α−置換グリシンアミド誘導体
JPH072788A (ja) 新規な経口活性を有するアゾール誘導体
EP1351954B1 (en) Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives
WO2002092593A1 (fr) Derives de 4-(4-pyridazinyl)pyrazole
CA2860099A1 (en) Imidazolylketone derivatives asd aldosterone synthase inhibitors